diabetic retinopathy semaglutide AAO: usually no worse with in T2D Semaglutide linked to increased risk

Mounjaro and Diphenhydramine Interaction: What You Need to Know At a glance Direct CYP-mediated interaction / none identified per FDA labeling Primary concern / pharmacodynamic overlap affecting GI motility Diphenhydramine anticholinergic load / moderate (slows gastric emptying) Tirzepatide GI side effect rate / nausea in 12.8 to 18.6% across SURPASS trials Severity rating in major DDI databases / minor to moderate Dose adjustment required / none, but timing separation may help Monitoring recommendation / watch for worsening nausea, constipation, or gastroparesis symptoms Risk populations / older adults, patients with diabetic gastroparesis, those on multiple anticholinergics Common diphenhydramine use case / OTC sleep aids and allergy relief (Benadryl, ZzzQuil) Alternative antihistamines with lower anticholinergic burden / cetirizine, loratadine, fexofenadine Why This Combination Raises Questions Tirzepatide (Mounjaro) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and widely prescribed off-label for weight management

Signs of pulmonary hypertension may include elevated neck veins, a loud P2 component of S2, a right-sided gallop, or right ventricular parasternal lift (13)

Vitamin C supplements and the risk of age-related cataract: A population-based prospective cohort study in women

The standard initial cutoff is 1,000 ng/mL

Frequently asked questions Can I take ipamorelin with SSRIs like sertraline or escitalopram